Proteomic Analysis of Laser Microdissected Ovarian Cancer Tissue with SELDI-TOF MS
The evolution of ovarian cancer will highly depend on platinum sensitivity or resistance. In an attempt to better understand this mechanism of resistance, we combined laser microdissection (LMD) of ovarian tumor cells with mass spectrometric techniques. To obtain disease-specific markers we isolated ovarian tumor cells with LMD without contamination of surrounding cells. Proteins were extracted by chemical lysis and subsequent peptide and protein information was gathered using surface-enhanced laser desorption/ionization-time of flight mass spectrometry.
Key wordsOvarian cancer SELDI-TOF MS Platinum resistance Laser microdissection Biomarkers
- 1.Heintz APM, Odicino F, Maisonneuve P, Quinn MA, Benedet JL and Creasman WT et al. (2006) Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynaecological Cancer. Int J Gynaecol Obstet 95 (suppl. 1), S161–192.Google Scholar
- 5.Stewart JJ, White JT, Yan X, Collins S, Drescher CW, Urban ND, et al. (2006) Proteins associated with cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol Cell Proteomics 5,433–443.Google Scholar
- 9.Cadron I, Van Gorp T, Amant F, Vergote I, Moerman Ph, Waelkens E, Daemen A, Van de Plas R, De Moor B, Zeillinger R. (2009) The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles. Anticancer Res. 29, 1039–1045.Google Scholar
- 11.Schultze K, Lahr G, Burgemeister R. (2000) The force of focused light in different areas of cell and molecular biology. J Mol Med 78, B21.Google Scholar
- 13.Diaz JL, Cazares LH, Corica A, Semmes OJ. (2004) Selective capture of prostatic basal cells and secretory epitheial cells for proteomic and genomic analysis. Urologic Oncology 329–336.Google Scholar